Published date: 24 January 2024
This notice was replaced on 24 January 2024
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Opportunity (published 24 January 2024, last edited 15 February 2024)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Immune sera and immunoglobulins - 33651500
Vaccines - 33651600
Location of contract
United Kingdom
Value of contract
£0
Procurement reference
CF-2116300D0O000000rwimUAA
Published date
24 January 2024
Closing date
29 February 2024
Closing time
1pm
Contract start date
1 July 2024
Contract end date
30 June 2028
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The provision of immunisation products indicated for the prevention of or protection from Respiratory Syncytial Virus (RSV) lower respiratory tract disease
Deliveries will be required up to a period of 2 years, with an option to extend for up to an additional 24 months.
Information about volumes for each lot is included in the Invitation to Offer documents.
More information
Additional text
-
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: support-health@atamis.co.uk
About the buyer
Contact name
Chantal Jockel
Address
10 South Colonnade
London
E14 5EA
GB
Share this notice
All content is available under the
